CA Patent

CA2607385C — Thiazole derivatives and their use for the treatment and/or prophylaxis of disorders and diseases

Assigned to Merck Serono SA · Expires 2014-12-16 · 11y expired

What this patent protects

The present invention is related to thiazole derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, pl…

USPTO Abstract

The present invention is related to thiazole derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

Drugs covered by this patent

Patent Metadata

Patent number
CA2607385C
Jurisdiction
CA
Classification
—
Expires
2014-12-16
Drug substance claim
No
Drug product claim
No
Assignee
Merck Serono SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.